Sutro Biopharma, Inc. (STRO)
Nasdaq: STRO · Biological Products, (No Diagnostic Substances) · South San Francisco, CA · filing with the SEC since 2006
The company now
Sutro Biopharma, Inc. is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in South San Francisco, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $102 million and a loss of $191 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.